Critical developmental periods in the pathogenesis of hypertension

Physiological Research

Volumn 61, Issue SUPPL. 1, 2012, Pages

  Kunes J ^a,b   Kadlecova M ^a,b   Vaneckova I ^a,b   Zicha, J ^a,b  

^a Cardiovascular Research Center   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Critical developmental periods; Developmental programming; Epigenetics; Hypertension; Rat

Indexed keywords

ANIMAL; ARTERIAL PRESSURE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; EPISTASIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERTENSION; PATHOLOGY; QUANTITATIVE TRAIT LOCUS; REVIEW; RISK FACTOR;

ANIMALS; ARTERIAL PRESSURE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; HYPERTENSION; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 84865263602     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. BARKER DJ, OSMOND C: Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1: 1077-1081, 1968.
2. BARKER DJ, OSMOND C: Low birth weight and hypertension. BMJ 297: 134-135, 1988.
3. BARKER DJ, BULL AR, OSMOND C, SIMMONDS SJ: Fetal and placental size and risk of hypertension in adult life. BMJ 301: 59-62, 1990.
4. BOGDARINA I, WELHAM S, KING PJ, BURNS SP, CLARK AJ: Epigenetic modification of the renin-Angiotensin system in the fetal programming of hypertension. Circ Res 100: 520-526, 2007. (Pubitemid 46673261)
5. BRENNER BM, GARCIA DL, ANDERSON S: Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1: 335-347, 1988.
6. BROWNIE AC, BERNARDIS LL, NIWA T, KAMURA S, SKELTON FR: The influence of age and sex on the development of adrenal regeneration hypertension. Lab Invest 15: 1342-1356, 1966.
7. CAMPBELL D: Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists. Clin Exp Pharmacol Physiol 3 (Suppl): S125-S131, 1996. (Pubitemid 26421904)
8. CHANDLER VL: Paramutation: From maize to mice. Cell 128: 641-645, 2007. (Pubitemid 46273579)
9. CHAO J, CHAO L: Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases. Pharmacol Res 35: 517-522, 1997. (Pubitemid 27420467)
10. CHAO J, JIN L, LIN KF, CHAO L: Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertens Res 20: 269-277, 1997.
11. CVETKOVIC B, SIGMUND CD: Understanding hypertension through genetic manipulation in mice. Kidney Int 57: 863-874, 2000. (Pubitemid 30434776)
12. DLOUHÁ H, KŘEČEK J, ZICHA J: Effect of age on hypertensive stimuli and the development of hypertension in Brattleboro rats. Clin Sci 57: 273-275, 1975. (Pubitemid 10101526)
13. ERHUMA A, MCMULLEN S, LANGLEY-EVANS SC, BENNETT AJ: Feeding pregnant rats a low-rotein diet alters the hepatic expression of SREBP-1c in their offspring via a glucocorticoid-related mechanism. Endocrine 36: 333-338, 2009.
14. FEINBERG AP: Epigenetics at the epicenter of modern medicine. JAMA 299: 1345-1350, 2008. (Pubitemid 351439080)
15. FOLKOW B, SVANBORG A: Physiology of cardiovascular aging. Physiol Rev 73: 725-764, 1993. (Pubitemid 24004651)
16. FORSDAHL A: Are poor living conditions in childhood and adolescence an important risk factor for atherosclerotic heart disease? Br J Prev Soc Med 31: 91-95, 1977. (Pubitemid 8143671)
17. GLUCKMAN PD, LILLYCROP KA, VICKERS MH, PLEASANTS AB, PHILLIPS ES, BEEDLE AS, BURDGE GC, HANSON MA: Metabolic plasticity during mammalian development is directionally dependent on early nutritional status. Proc Natl Acad Sci U S A 104: 12796-12800, 2007. (Pubitemid 47255234)
18. GOLDBERG AD, ALLIS CD, BERNSTEIN E: Epigenetics: A landscape takes shape. Cell 128: 635-638, 2007. (Pubitemid 46273578)
19. GUIDICELLI JF, FRESLON JL, GLASSON S, RICHTER C: Captopril and hypertension development in the SHR. Clin Exp Hypertens 2: 1083-1096, 1980. (Pubitemid 11172187)
20. HARRAP SB, VAN DER MERWE WM, GRIFFIN SA, MACPHERSON F, LEVER AF: Brief angiotensin-converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-Term. Hypertension 16: 603-614, 1990.
21. HO SM, TANG WY: Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: An emphasis on fetal-based adult diseases. Reprod Toxicol 23: 267-282, 2007.
22. HOET JJ, HANSON MA: Intrauterine nutrition: Its importance during critical periods for cardiovascular and endocrine development. J Physiol 514: 617-627, 1999. (Pubitemid 29060309)
23. HOLLIDAY R: Mechanisms for the control of gene activity during development. Biol Rev Camb Philos Soc 65: 431-471, 1990.
24. HUXLEY RR, NEIL A, COLLINS R: Unravelling the fetal origins hypothesis: Is there an inverse association between birth-weight and subsequent blood pressure? Lancet 360: 659-665, 2002. (Pubitemid 35232333)
25. INAGAMI T: The renin-Angiotensin system. Essays Biochem 8: 147-164, 1994.
26. INAGAMI T: Recent progress in molecular and cell biological studies of angiotensin receptors. Curr Opin Nephrol Hypertens 4: 47-54, 1995.
27. IWANAMI J, MOGI M, IWAI M, HORIUCHI M: Inhibition of the renin-Angiotensin system and target organ protection. Hypertens Res 32: 229-237, 2009.
28. JOHNSTON CI, MENDELSOHN FA, CUBELA RB, JACKSON B, KOHZUKI M, FABRIS B: Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: Studies ex vivo after administration of ACE inhibitors. J Hypertens 6 (Suppl): S17-S22, 1988. (Pubitemid 19046450)
29. KATOVICH MJ, GELBAND CH, REAVES P, WANG HW, RAIZADA MK: Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR. Am J Physiol 277: H1260-H1264, 1999. (Pubitemid 29459641)
30. KELLER G, ZIMMER G, MALL G, RITZ E, AMAN K: Nephron number in patients with primery hypertension. N Engl J Med 348: 101-108, 2003. (Pubitemid 36056716)
31. KŘEČEK J: The theory of critical developmental periods and postnatal development of endocrine functions. In: The Biopsychology of Development. E TOBACH, LR ARONSON, E SHAW (eds), Academic Press, Inc., New York and London, 1971, pp 233-248.
32. KŘEČEK J, DLOUHÁ H, ZICHA J: Salt supply in early life and possible consequences for hypertension in adult life. Bibl Nutr Dieta 1: 121-130, 1982.
33. KUNEŠ J, ZICHA J: Developmental windows and environment as important factors in the expression of genetic information: A cardiovascular physiologist's view. Clin Sci 111: 295-305, 2006. (Pubitemid 44690188)
34. LAW CM, SHIELL AW: Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens 14: 935-941, 1996. (Pubitemid 26306057)
35. LILLYCROP KA, SLATER-JEFFERIES JL, HANSON MA, GODFREY KM, JACKSON AA, BURDGE GC: Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 97: 1064-1073, 2007. (Pubitemid 46925358)
36. LIN KF, CHAO L, CHAO J: Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension 30: 307-313, 1997. (Pubitemid 27446085)
37. LU D, RAIZADA MK, IYER S, REAVES P, YANG H, KATOVICH MJ: Losartan versus gene therapy: Chronic control of high blood pressure in spontaneously hypertensive rats. Hypertension 30: 363-370, 1997. (Pubitemid 27446094)
38. ORDOVÁS JM, SMITH CE: Epigenetics and cardiovascular disease. Nat Rev Cardiol 7: 510-519, 2010.
39. OZANNE SE: Metabolic programming in animals. Br Med Bull 60: 143-152, 2001. (Pubitemid 34123509)
40. PEERS A, CAMPBELL DJ, WINTOUR EM, DODIC M: The peripheral renin-Angiotensin system is not involved in the hypertension of sheep exposed to prenatal dexamethasone. Clin Exp Pharmacol Physiol 28: 306-311, 2001. (Pubitemid 32250718)
41. ROSE G: Familial patterns in ischaemic heart disease. Br J Prev Soc Med 18: 75-80, 1964.
42. RUIZ-ORTEGA M, LORENZO O, RUPÉREZ M, ESTEBAN V, SUZUKI Y, MEZZANO S, PLAZA JJ, EGIDO J: Role of the renin-Angiotensin system in vascular diseases: Expanding the field. Hypertension 38: 1382-1387, 2001. (Pubitemid 34033420)
43. SCHLEMM L, HAUMANN HM, ZIEGNER M, STIRNBERG B, SOHN A, ALTER M, PFAB T, KALACHE KD, GUTHMANN F, HOCHER B: New evidence for fetal insulin hypothesis: Fetal angiotensin M235T polymorphysm is associated with birth weight and elevated fetal total glycated hemoglobin at birth. J Hypertens 28: 732-739, 2010.
44. SCOTT JP, STEWART JM, DEGHETT VJ: Critical periods in the organization of systems. Develop Psychobiol 7: 489-513, 1974.
45. TURUNEN MP, AAVIK E, YLÄ-HERTTUALA S: Epigenetics and atherosclerosis. Biochim Biophys Acta 1790: 886-891, 2009.
46. WATERLAND RA, MICHELS KB: Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 27: 363-388, 2007. (Pubitemid 351373362)
47. WU J-N, BERECEK KH: Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 22: 139-146, 1993. (Pubitemid 23234058)
48. ZICHA J, ŠTOLBA P, POHLOVÁ I, KUNEŠ J, JELÍNEK J: A different role of digoxin-like factor in the maintenance of elevated blood pressure in rats treated with DOCA and saline in youth or only in adulthood. J Hypertens 2 (Suppl): S481-S483, 1984.
49. ZICHA J, KUNEŠ J: Experimental hypertension in young and adult animals. Hypertension 8: 1096-1104, 1986. (Pubitemid 17228779)
50. ZICHA J, KUNEŠ J, LÉBL M, POHLOVÁ I, JELÍNEK J: Haemodynamics and the participation of pressor systems in young and adult rats with age-dependent DOCA-salt hypertension. Physiol Bohemoslov 36: 89-92, 1987. (Pubitemid 17039694)
51. ZICHA J, KUNEŠ J: Ontogenetic aspects on hypertension development: Analysis in the rat. Physiol Rev 79: 1227-1282, 1999. (Pubitemid 29473316)
52. ZICHA J, DOBEŠOVÁ Z, KUNEŠ J: Late blood pressure reduction in SHR subjected to transient captopril treatment in youth: Possible mechanisms. Physiol Res 57: 495-498, 2008.
53. ZICHA J, VANĚČKOVÁ I, KUNEŠ J: System analysis in hypertension: Complementary role of physiologists and geneticists. Physiol Res 59: 837-839, 2010.